Q
QuantAbundance

Notícias

Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

30,844 signal articles · 163 in last 24h · 157,252 total before filter · latest 33m ago
163last 24h
864last 7d
143● bullish (7d)
77● bearish (7d)
214publishers
AllMacro197Earnings134M&A101Regulatory18Product20Analyst23
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Can Growth Alone Carry Autodesk Stock Back Up?
Trefis7d agoneutral
Can Growth Alone Carry Autodesk Stock Back Up?

Autodesk (ADSK) trades near $217, about 32% lower than a year ago. Investors fear AI tools could disrupt its software, and the shares dropped after the late-August report. Yet revenue over the past twelve months reached $7.8 billion, up 17.9%. A three-year scenario on its own numbers shows how much of that growth could reach the stock.

Why Did Hut 8 (HUT) Shares Climb Today?
Simply Wall St.7d agoneutral
Why Did Hut 8 (HUT) Shares Climb Today?

Recent comments from Hut 8 (HUT) co-founder Marc van der Chijs about AI safety and Bitcoin drew fresh attention to the company’s move into AI data centers and its role in high performance computing. For context, Hut 8 shares closed at US$98.74, with a 1-day share price return of 8.52% and a 30-day share price return of 22.11%, while the 90-day share price return fell 18.06% and the 1-year total shareholder return reached 160.73%. This suggests strong longer term momentum even after recent...

Eli Lilly (LLY) Could Be 22% Undervalued On New Breast Cancer Approval
Simply Wall St.7d agoneutral
Eli Lilly (LLY) Could Be 22% Undervalued On New Breast Cancer Approval

Eli Lilly (LLY) is back in focus after the U.S. Food and Drug Administration granted full approval for Inluriyo, used with Verzenio in certain ESR1 mutated metastatic breast cancer patients. Eli Lilly’s share price has eased over the past month, with a 30-day share price return of 8.16% in the red. However, the 1-year total shareholder return of 53.68% and roughly 4x gain over five years point to momentum that remains firmly intact. Compare Eli Lilly’s oncology and obesity story with other...

Paramount reaches deal with states to settle their case challenging Warner buyout, AP source says
Associated Press7d agobearish
Paramount reaches deal with states to settle their case challenging Warner buyout, AP source says

Skydance-owned Paramount reached a settlement Monday with a group of state attorneys general that had sued to challenge the company’s buyout of Warner Bros. Discovery, effectively paving the way for the mega merger to move forward, a person familiar with the matter told the AP. Details of the settlement with the states were not immediately available, but were expected to be revealed later in the day. Paramount said the allegations were meritless, but previously agreed to delay its transaction well into next year so the case could make its way through court.

eBay Upgraded, Airbnb Downgraded: Updated Rankings on Top Blue-Chip Stocks
InvestorPlace7d agoneutral
eBay Upgraded, Airbnb Downgraded: Updated Rankings on Top Blue-Chip Stocks

During these busy times, it pays to stay on top of the latest profit opportunities. And today’s blog post should be a great place to start. After taking a close look at the latest data on institutional buying pressure and each company’s fundamental health, I decided to revise my Stock Grader recommendations for 95 big blue chips. Chances are that you have at least one of these stocks in your portfolio, so you may want to give this list a skim and act accordingly. This Week’s Ratings Changes: Upg

Cybersecurity Stocks Extend Gains on AI Safety Warnings: CrowdStrike and Okta Rise 4%, Palo Alto Ticks Up
24/7 Wall St.7d agoneutral
Cybersecurity Stocks Extend Gains on AI Safety Warnings: CrowdStrike and Okta Rise 4%, Palo Alto Ticks Up

Cybersecurity stocks are extending last week’s advance into Monday’s midday session, and the leaders today are identity and endpoint names rather than the network security franchise. CrowdStrike Holdings (NASDAQ:CRWD) stock is up 4.02% to $247.20, running well ahead of the sector fund and the broader technology benchmark. Also gaining, Okta (NASDAQ:OKTA) shares are climbing 4.05% […]

1st Source (SRCE): Buy, Sell, or Hold Post Q2 Earnings?
StockStory7d agoneutral
1st Source (SRCE): Buy, Sell, or Hold Post Q2 Earnings?

1st Source’s 26.1% return over the past six months has outpaced the S&P 500 by 9.8%, and its stock price has climbed to $85.89 per share. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.

Paramount Talks Include Penalty for Missing 30-Film Pledge
Bloomberg7d agobearishVIDEO
Paramount Talks Include Penalty for Missing 30-Film Pledge

Geetha Ranganathan, Bloomberg Intelligence analyst, joined Bloomberg's Paul Sweeney and Scarlet Fu to discuss the latest on the ongoing Paramount and Warner Bros. merger. The settlement talks between Paramount Skydance Corp. and California officials over the planned acquisition of Warner Bros. Discovery Inc. are said to include a financial penalty if the company fails to make good on a promise to distribute 30 films per year in theaters. Paramount would have to pay $30 million for each film that falls short of that goal, according to two people familiar with the discussions who asked to not be identified because the negotiations are private. It could also be forced to sell its stake in Miramax, the studio behind movies such as Pulp Fiction, if it fails to meet the target, one of the people said.

What Happens To Lennar Stock If Its Home Sales Keep Slowing?
Trefis7d agoneutral
What Happens To Lennar Stock If Its Home Sales Keep Slowing?

Lennar (LEN) stock has lost about 41% over the past year, and on September 18 it closed at the bottom of its 52-week range. The bigger risk sits inside the business. Its plan to rebuild profit depends on selling homes at a steady pace, and its own numbers show that pace slipping.

Craneware Gets a Painful Growth Reset
Moby7d agoneutral
Craneware Gets a Painful Growth Reset

The healthcare-software group plunged after cyber fallout and disruption to America’s 340B drug-pricing market forced management to slash near-term revenue expectations.